SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:liu-184419"
 

Sökning: onr:"swepub:oai:DiVA.org:liu-184419" > The benefits, costs...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005630naa a2200577 4500
001oai:DiVA.org:liu-184419
003SwePub
008220422s2022 | |||||||||||000 ||eng|
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1844192 URI
0247 a https://doi.org/10.1016/j.lanepe.2021.1002942 DOI
040 a (SwePub)liu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Czypionka, Thomasu Inst Adv Studies, Austria; London Sch Econ & Polit Sci, England4 aut
2451 0a The benefits, costs and feasibility of a low incidence COVID-19 strategy
264 1b Elsevier,c 2022
338 a electronic2 rdacarrier
500 a Funding Agencies|European UnionEuropean Commission [101016233]; Max Planck SocietyMax Planck SocietyFoundation CELLEX; "Netzwerk Universitatsmedizin" (NUM) project egePan [01KX2021]; Digital Society research program - Ministry of Culture and Science of the German State of North Rhine-Westphalia; University of Malta; Luxembourg National Research Fund (FNR) as part of the COVID-19 Fast-Track research project Cov-Screen [COVID-19/2020- 1/14715687]; European Research Council (ERC) under the European UnionEuropean Research Council (ERC) [863664]; Slovenian Research AgencySlovenian Research Agency - Slovenia [P1-0403, J1-2457]; University of Crete; Maastricht University; European CommissionEuropean CommissionEuropean Commission Joint Research Centre; UK Economic and Social Research Council (ESRC)UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/T014164/1]; UK Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/S035818/1]; Leverhulme TrustLeverhulme Trust [RPG-2020-295]; Wellcome TrustWellcome Trust [209519/Z/17/Z, 106612/Z/14/Z]; Polish National Science Centre OPUS grant [2019/33/B/NZ2/00956]; Luxembourg National Research Fund (FNR) as part of the COVID-19 Fast-Track research project CO-INFECTOMICS [COVID-19/2020-1/14729513]; European Research Council (ERC) under the European Unions Horizon 2020 research and innovation programmeEuropean Research Council (ERC) [863664]
520 a In the summer of 2021, European governments removed most NPIs after experiencing prolonged second and third waves of the COVID-19 pandemic. Most countries failed to achieve immunization rates high enough to avoid resurgence of the virus. Public health strategies for autumn and winter 2021 have ranged from countries aiming at low incidence by re-introducing NPIs to accepting high incidence levels. However, such high incidence strategies almost certainly lead to the very consequences that they seek to avoid: restrictions that harm people and economies. At high incidence, the important pandemic containment measure test-trace-isolate-support becomes inefficient. At that point, the spread of SARS-CoV-2 and its numerous harmful consequences can likely only be controlled through restrictions. We argue that all European countries need to pursue a low incidence strategy in a coordinated manner. Such an endeavour can only be successful if it is built on open communication and trust. Copyright (C) 2021 The Authors. Published by Elsevier Ltd.
650 7a SAMHÄLLSVETENSKAPx Statsvetenskapx Studier av offentlig förvaltning0 (SwePub)506022 hsv//swe
650 7a SOCIAL SCIENCESx Political Sciencex Public Administration Studies0 (SwePub)506022 hsv//eng
7001 a Iftekhar, Emil N.u Max Planck Inst Dynam & Self Org, Germany4 aut
7001 a Prainsack, Barbarau Univ Vienna, Austria4 aut
7001 a Priesemann, Violau Max Planck Inst Dynam & Self Org, Germany4 aut
7001 a Bauer, Simonu Max Planck Inst Dynam & Self Org, Germany4 aut
7001 a Valdez, Andre Calerou Rhein Westfal TH Aachen, Germany4 aut
7001 a Cuschieri, Sarahu Univ Malta, Malta4 aut
7001 a Glaab, Enricou Univ Luxembourg, Luxembourg4 aut
7001 a Grill, Evau Ludwig Maximilians Univ Munchen, Germany4 aut
7001 a Krutzinna, Jennyu Univ Bergen, Norway4 aut
7001 a Lionis, Christosu Linköpings universitet,Avdelningen för prevention, rehabilitering och nära vård,Medicinska fakulteten,Univ Crete, Greece4 aut0 (Swepub:liu)chrli18
7001 a Machado, Helenau Univ Minho, Portugal4 aut
7001 a Martins, Carlosu Univ Porto, Portugal4 aut
7001 a Pavlakis, George N.u NCI, MD 20892 USA4 aut
7001 a Perc, Matjazu Univ Maribor, Slovenia; China Med Univ, Taiwan4 aut
7001 a Petelos, Elenau Univ Crete, Greece; Maastricht Univ, Netherlands4 aut
7001 a Pickersgill, Martynu Univ Edinburgh, Scotland4 aut
7001 a Skupin, Alexanderu Univ Luxembourg, Luxembourg4 aut
7001 a Schernhammer, Evau Med Univ Vienna, Austria4 aut
7001 a Szczurek, Ewau Univ Warsaw, Poland4 aut
7001 a Tsiodras, Sotiriosu Natl & Kapodistrian Univ Athens, Greece4 aut
7001 a Willeit, Peteru Med Univ Innsbruck, Austria; Univ Cambridge, England4 aut
7001 a Wilmes, Paulu Univ Luxembourg, Luxembourg4 aut
7102 a Inst Adv Studies, Austria; London Sch Econ & Polit Sci, Englandb Max Planck Inst Dynam & Self Org, Germany4 org
7730 t The Lancet Regional Healthd : Elsevierg 13q 13x 2666-7762
8564 u https://liu.diva-portal.org/smash/get/diva2:1653666/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 u https://doi.org/10.1016/j.lanepe.2021.100294
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-184419
8564 8u https://doi.org/10.1016/j.lanepe.2021.100294

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy